Phase I trial of a novel hTERT vaccination strategy addressing T effector cells and immune-suppressor mechanisms

J. Spicer; V. Kwatra; C. Verma; K. Ioannou; R. Goldstein; T. Brier; J. Eremin; N. Zareian; L. Walker; D. Lobo; F. Farzaneh; O. Eremin

doi:10.1093/annonc/mdy288.030

Phase I trial of a novel hTERT vaccination strategy addressing T effector cells and immune-suppressor mechanisms

J. Spicer, V. Kwatra, C. Verma, K. Ioannou, R. Goldstein, T. Brier, J. Eremin, N. Zareian, L. Walker, D. Lobo, F. Farzaneh, O. Eremin

Comprehensive Cancer Centre

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	viii412
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy288.030
Publication status	Published - 1 Oct 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdy288.030

Cite this

Spicer, J., Kwatra, V., Verma, C., Ioannou, K., Goldstein, R., Brier, T., Eremin, J., Zareian, N., Walker, L., Lobo, D., Farzaneh, F., & Eremin, O. (2018). Phase I trial of a novel hTERT vaccination strategy addressing T effector cells and immune-suppressor mechanisms. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii412. https://doi.org/10.1093/annonc/mdy288.030

@article{c72c5ec641b64f1fa344df9ac63aa5fa,

title = "Phase I trial of a novel hTERT vaccination strategy addressing T effector cells and immune-suppressor mechanisms",

author = "J. Spicer and V. Kwatra and C. Verma and K. Ioannou and R. Goldstein and T. Brier and J. Eremin and N. Zareian and L. Walker and D. Lobo and F. Farzaneh and O. Eremin",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy288.030",

language = "English",

volume = "29",

pages = "viii412",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Elsevier",

}

Spicer, J, Kwatra, V, Verma, C, Ioannou, K, Goldstein, R, Brier, T, Eremin, J, Zareian, N, Walker, L, Lobo, D, Farzaneh, F & Eremin, O 2018, 'Phase I trial of a novel hTERT vaccination strategy addressing T effector cells and immune-suppressor mechanisms', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii412. https://doi.org/10.1093/annonc/mdy288.030

TY - JOUR

T1 - Phase I trial of a novel hTERT vaccination strategy addressing T effector cells and immune-suppressor mechanisms

AU - Spicer, J.

AU - Kwatra, V.

AU - Verma, C.

AU - Ioannou, K.

AU - Goldstein, R.

AU - Brier, T.

AU - Eremin, J.

AU - Zareian, N.

AU - Walker, L.

AU - Lobo, D.

AU - Farzaneh, F.

AU - Eremin, O.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081527835&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy288.030

DO - 10.1093/annonc/mdy288.030

M3 - Article

C2 - 32137034

SN - 0923-7534

VL - 29

SP - viii412

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Phase I trial of a novel hTERT vaccination strategy addressing T effector cells and immune-suppressor mechanisms

UN SDGs

Access to Document

Other files and links

Cite this